PAO NOVATEK
PAO NOVATEK Fundamental Analysis
PAO NOVATEK (NOVKY) shows moderate financial fundamentals with a PE ratio of 1.60, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with strong year-over-year growth of 12.71%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 63.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze NOVKY's fundamental strength across five key dimensions:
Efficiency Score
WeakNOVKY struggles to generate sufficient returns from assets.
Valuation Score
ModerateNOVKY shows balanced valuation metrics.
Growth Score
ModerateNOVKY shows steady but slowing expansion.
Financial Health Score
WeakNOVKY carries high financial risk with limited liquidity.
Profitability Score
WeakNOVKY struggles to sustain strong margins.
Key Financial Metrics
Is NOVKY Expensive or Cheap?
P/E Ratio
NOVKY trades at 1.60 times earnings. This suggests potential undervaluation.
How Well Does NOVKY Make Money?
No data available.
Following the Money - Real Cash Generation
No data available.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
N/A
vs 25 benchmark
Current Ratio
Current assets to current liabilities
N/A
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
N/A
vs 25 benchmark
ROA
Return on assets percentage
N/A
vs 25 benchmark
ROCE
Return on capital employed
N/A
vs 25 benchmark
How NOVKY Stacks Against Its Sector Peers
| Metric | NOVKY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 19.94 | N/A |
| ROE | N/A | 987.00% | N/A |
| Net Margin | N/A | -42983.00% (disorted) | N/A |
| Debt/Equity | N/A | -0.60 (disorted) | N/A |
| Current Ratio | N/A | 4.67 | N/A |
| ROA | N/A | -11498250.00% (disorted) | N/A |
Historical Growth Performance
5-Year Growth Trajectory
This section reviews PAO NOVATEK's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
80.56%
Industry Style: Cyclical, Value, Commodity
High GrowthEPS CAGR
-42.54%
Industry Style: Cyclical, Value, Commodity
DecliningFCF CAGR
17.07%
Industry Style: Cyclical, Value, Commodity
High Growth